Conviction
YC S25New York City, US · Founded 2025 · 2 employees · Hiring · 4 known investors
Find your way into Conviction
907 people in our graph share verified history with the Conviction team — schools, employers, funds. One of them is your warm intro.
Parachute provides AI governance and compliance software for hospitals, automating the evaluation, deployment, and monitoring of clinical AI systems to reduce risk and accelerate pilot programs. The platform helps healthcare organizations manage bias, drift, and privacy issues while maintaining regulatory compliance and audit trails.
Also known as Parachute · Parachute AI
Founders & leadership· Y Combinator alumni (S25)
Conviction was founded in 2025 by Aria Vikram and Tony Yamin.
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seed roundFeb 2026
Rampersand (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Conviction, which operates the product Parachute, builds governance infrastructure for clinical artificial intelligence. Its platform is aimed at hospitals and health systems that need to evaluate, approve, deploy and continuously monitor AI tools — including electronic health record plug-ins such as Epic extensions, third-party vendor models, and models developed in-house, such as imaging algorithms. The company positions the product around two stated problems: patient-safety risk from AI errors and the cost of slow or stalled AI pilot programs.
The product is organized into four phases. Discovery and prioritization uses AI agents to map a hospital's clinical gaps, goals and budget to available vendors, while a review engine flags compliance issues in vendor documentation. Evaluation and approval applies automated scoring and stress testing of accuracy, safety and bias in place of manually written test scripts. Deployment and monitoring provides real-time observability of performance, drift and bias, with alerts when a metric falls below a threshold. An audit-and-prove phase maintains a documentation trail of approvals, tests, changes and runtime metrics intended for regulators and litigation. Parachute also operates a Vendor Marketplace that ranks AI vendors against hospital-specific needs by fit, risk and impact, and states that the platform integrates with a hospital's existing stack.
The company frames its market around regulatory requirements it cites, including HTI-1, the Colorado AI Act, California SB 3030 and the White House AI Action Plan, alongside its claim that more than 2,000 clinical AI tools have entered the market and that lean hospital IT teams cannot vet and monitor each model.
Founding story
Co-founders Aria Vikram (Founder/CEO) and Tony Yamin (Founder/CTO) say they conceived Parachute while deploying AI at Columbia University Irving Medical Center, where they repeatedly encountered obstacles to hospital AI adoption: a proliferation of clinical AI tools, new rules requiring auditable evidence of safety, equity and efficacy, small IT teams unable to vet and monitor every model, and pilots that failed to reach production for lack of deployment infrastructure. Vikram was previously an NLP researcher at Columbia and deployed AI chatbots for doctors at CUIMC; Yamin previously built machine-learning infrastructure for the U.S. Department of Defense at Booz Allen.
Business model
Software sold to hospitals and health systems for AI governance, combined with a two-sided Vendor Marketplace in which AI vendors apply to be listed and matched to hospital needs; a launch offer of 50% off a marketplace listing was extended to Y Combinator AI companies.
Traction
Columbia University Irving Medical Center uses Parachute to track live models in real time, according to the company's Y Combinator launch post. The company was named in a Y Combinator-linked list of promising startups from the Summer 2025 batch.
Latest developments
Parachute was publicly launched during the Y Combinator Summer 2025 batch, and the company published content on clinical AI governance, the White House AI Action Plan and its Vendor Marketplace. A September 4, 2025 article named it among promising startups from the batch.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
An early-stage entrant in clinical AI governance, citing regulatory drivers (HTI-1, Colorado AI Act, California SB 3030, the White House AI Action Plan) and the volume of AI-enabled medical devices and clinical AI tools as the basis for demand.
The company describes end-to-end coverage of the clinical AI lifecycle — vendor discovery, automated evaluation, post-deployment monitoring and audit documentation — delivered through AI agents rather than added hospital headcount or manual test scripts, plus a marketplace that maps vendor products to hospital-specific gaps and compliance needs.
Technology
AI agents that map hospital gaps to vendor offerings, a document review engine that flags compliance issues in vendor materials, automated benchmarking, scoring and stress testing for accuracy, safety and bias, real-time observability of model performance, drift and bias with threshold-based alerting, and an immutable audit trail recording approvals, tests, changes and runtime metrics.
Go-to-market
Direct sales to hospital leaders through demo bookings and founder contact, paired with an inbound vendor application funnel for AI companies seeking marketplace listings; the launch post targeted health system decision-makers seeking to move stalled pilots live and AI vendors seeking distribution.
Hospitals and health systems — including their IT, compliance and clinical committee decision-makers — and, on the supply side, vendors selling AI products into healthcare.
Geography
Y Combinator lists the company in San Francisco, with a Founding Engineer role posted in San Francisco, CA.
History
The company was founded in 2025 and participated in Y Combinator's Summer 2025 batch, launching Parachute during the batch with a public launch post and demo video. Y Combinator lists Harj Taggar as primary partner and a team size of two.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 5
by search overlapCompanies competing with Conviction for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 4
launches, deals, and filingsListed in coverage of 'The Most Promising Startups To Watch From YC Summer 2025 Batch'.
According to the company's launch post, CUIMC uses Parachute to track live AI models in real time.
Parachute published details of a Vendor Marketplace that matches hospital-specific needs to evidence-based AI vendor solutions, ranked by fit, risk and impact.
The founders published a launch post introducing Parachute, an end-to-end governance platform for hospitals to evaluate, deploy and monitor clinical AI, including a demo video and a launch offer of 50% off a marketplace listing for YC AI companies.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Convictionparachute-ai.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Conviction do?
- Y Combinator-backed startup building governance infrastructure for hospitals to evaluate, deploy and monitor clinical AI.
- Who founded Conviction?
- Conviction was founded by Aria Vikram, Tony Yamin in 2025.
- Who are Conviction's investors?
- Conviction's investors include Y Combinator, Rampersand, Susa Ventures, Upfront Ventures.
- Where is Conviction headquartered?
- Conviction is headquartered in New York City, US.






